Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
1,335
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy

Jianbo Lia Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Tiange Fengb Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
,
Weijing Yangb Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
,
Yaru Xub Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
,
Shuaishuai Wangb Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
,
Huijie Caib Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
,
Zhilei Liua Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Hong Qiangb Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaView further author information
&
Jinjie Zhangb Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China;c Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1890-1902 | Received 13 Jul 2021, Accepted 30 Aug 2021, Published online: 14 Sep 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.